Diagnosis of Fusarium Infections: Approaches to Identification by the Clinical Mycology Laboratory

Current Fungal Infection Reports

Volumn 9, Issue 3, 2015, Pages 135-143

  van Diepeningen, Anne D ^a   Brankovics, Balázs ^a,b   Iltes, Jearidienne ^a   van der Lee, Theo A J ^c   Waalwijk, Cees ^c  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Antifungal susceptibility; Clinical observations; DNA based diagnostic tools; Fusarium; Multi locus sequence typing; Peptide based diagnostic tools

Indexed keywords

ANTIFUNGAL AGENT; ELONGATION FACTOR 1ALPHA; PEPTIDE; RNA POLYMERASE II;

ANTIFUNGAL SUSCEPTIBILITY; BLOOD EXAMINATION; CLINICAL LABORATORY; CLINICAL OBSERVATION; DNA DETERMINATION; DNA HYBRIDIZATION; DNA SEQUENCE; FUNGAL CELL WALL; FUNGAL STRUCTURES; FUNGUS GROWTH; FUNGUS HYPHAE; FUNGUS IDENTIFICATION; FUSARIOSIS; FUSARIUM; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; KERATOMYCOSIS; LABORATORY TEST; MICROSCOPY; MORTALITY; MYCOLOGY; NONHUMAN; ONYCHOMYCOSIS; POLYMERASE CHAIN REACTION; RADIODIAGNOSIS; REVIEW; SKIN DEFECT; SKIN NECROSIS; STRUCTURE ANALYSIS;

EID: 84939253034     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-015-0225-2     Document Type: Review

References (101)

1. Geiser DM, Aoki T, Bacon CW, et al. One fungus, one name: defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology. 2013;103:400–8. This paper defines the phylogenetic cluster of what species in view of this review and other works are to be considered as “Fusarium”. This definition is supported by more than 60 experts.
2. Leslie JF, Summerell BA. The Fusarium laboratory manual. Oxford: Blackwell Publishing Ltd; 2006.
3. van Diepeningen AD, Al-Hatmi AMS, Brankovics B, de Hoog GS. Taxonomy and clinical spectra of Fusarium species: where do we stand in 2014? Clin Microbiol Rep. 2014;1(1):10–8. This paper details what species from within the genus Fusarium are capable of causing human disease and provide an overview of the actual symptoms caused.
4. Nucci M, Varon AG, Garnica M, et al. Increased incidence of invasive fusariosis with cutaneous portal of entry. Brazil Emerg Infect Dis. 2013;19:1567–72.
5. Dalyan Cilo B, Al-Hatmi ASM, Seyedmousavi S, et al. Emerging Fusarioses at a University Hospital in Turkey: a retrospective study 1995–2014. Eur J Clin Microbiol Infect Dis. 2015. doi:10.1007/s10096-015-2405-y.
6. O'Donnell K, Sutton DA, Fothergill A, et al. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol. 2008;46(8):2477–90.
7. O’Donnell K, Gueidan C, Sink S, et al. A two-locus DNA sequence database for typing plant and human pathogens within the Fusarium oxysporum species complex. Fungal Genet Biol. 2009;46(12):936–48.
8. O'Donnell K, Sutton DA, Rinaldi MG, Gueidan C, Crous PW, Geiser DM. Novel multilocus sequence typing scheme reveals high genetic diversity of human pathogenic members of the Fusarium incarnatum-F. equiseti and F. chlamydosporum species complexes within the United States. J Clin Microbiol. 2009;47(12):3851–61.
9. O'Donnell K, Sutton DA, Rinaldi. Internet-accessible DNA sequence database for identifying Fusaria from human and animal infections. J Clin Microbiol. 2010;48(10):3708–18.
10. Lortholary O, Obenga G, Biswas P, et al. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. 2010;54(10):4446–4450.
11. Migheli Q, Balmas V, et al. Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in Northern and Central Italy. J Clin Microbiol. 2010;48(4):1076–84.
12. van Diepeningen AD, Feng P, Ahmed S, Sudhadham M, Bunyaratavej S, de Hoog GS. Spectrum of Fusarium infections in tropical dermatology evidenced by multilocus sequencing typing diagnostics. Mycoses. 2015;58(1):48–57.
13. Al-Hatmi AM, Bonifaz A, de Hoog G, et al. Keratitis by Fusarium temperatum, a novel opportunist. BMC Infect Dis. 2014;14(1):588.
14. Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20(4):695–704.
15. Tortorano AM, Richardson M, Roilides E, et al. ESCMID & ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp, Scedosporium spp, and others. Clin Microbiol Infect. 2014;20 Suppl 3:27–46. The recent guidelines give suggestions for the diagnosis of Fusarium and other hyalohyphomycetes and more importantly recommendation on how to treat them once diagnosed.
16. Kebabcı N, van Diepeningen AD, Ener B, et al. Fatal breakthrough infection with Fusarium andiyazi: new multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay. Mycoses. 2014;57(4):249–55.
17. Al-Hatmi AMS, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrobial Chemother. 2015;70(4):1068–71.
18. Vasantha Ruban V, Geraldine P, Kaliamurthy J, Jesudasan CA, Thomas PA. Keratitis due to Fusarium langsethiae: clinical profile, molecular identification, and susceptibility to antifungals. Mycopathologia. 2015. doi:10.1007/s11046-015-9866-5.
19. Brasnu E, Bourcier T, Dupas B, et al. In vivo confocal microscopy in fungal keratitis. Br J Ophthamol. 2007;91(5):588–91.
20. Wang L, Zhang J, Sun S, Zhang Y. In vivo confocal microscopic characteristics of fungal keratitis. Life Sci J. 2008;5(1):51–4.
21. Vaddavalli PK, Garg P, Sharma S, Sangwan VS, Rao GN, Thomas R. Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis. Ophthalmology. 2011;118(1):29–35.
22. Agarwal T, Bandivadekar P, Satpathy G, Sharma N, Titiyal JS. Detection of fungal hyphae using smartphone and pocket magnifier: going cellular. Cornea. 2015;34(3):355–7.
23. Anaissie E, Kantarjian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore). 1988;67(2):77–83.
24. Bryan CS. Clinical implications of positive blood cultures. Clin Microbiol Rev. 1989;2(4):329–53.
25. Tortorano AM, Esposto MC, Prigitano A, et al. Cross-reactivity of Fusarium spp. In the Aspergillus galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol. 2012;50(3):1051–3.
26. Rimek D, Singh J, Kappe R. Cross-reactivity of the PLATELIA CANDIDA antigen detection enzyme immunoassay with fungal antigen extracts. J Clin Microbiol. 2003;41(7):3395–8.
27. Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1→3)-β-d-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. Med Mycol. 1997;35(5):371–4.
28. Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol. 2008;190(6):1605–9.
29. Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis. 2011;52(9):1144–55.
30. Marom EM, Kontoyiannis DP. Imaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients. Curr Opin Infect Dis. 2011;24(4):309–14.
31. Watts JC, Chandler FW. Fusariosis. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, editors. Pathology of infectious diseases, vol. 2. 2 1st ed. Hong Kong: Stamford, Appleton & Lange Co; 1997. p. 999–1001.
32. Bennet JE. Introduction to mycoses. In: Mandell JL, Bennet JE, Dolin R, editors. Principles and practice of infectious diseases. 7. Philadelphia: Churchill Livingstone; 2009. p. 3221–4.
33. Kaufman L, Standard PG, Jalbert M, Kraft DE. Immunohistologic identification of Aspergillus spp. and other hyaline fungi by using polyclonal fluorescent antibodies. J Clin Microbiol. 1997;35(9):2206–9.
34. Saito T, Imaizumi M, Kudo K, et al. Disseminated Fusarium infection identified by the immunohistochemical staining in a patient with a refractory leukemia. Tohoku J Exp Med. 1999;187(1):71–7.
35. Hayden RT, Isotalo PA, Parrett T, et al. In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol. 2003;12(1):21–6.
36. Montone KT, Livolsi VA, Lanza DC, et al. Rapid In-situ hybridization for dematiaceous fungi using a broad-spectrum oligonucleotide DNA probe. Diagn Mol Pathol. 2011;20(3):180–3.
37. Okubo Y, Shinozaki M, Wakayama M, et al. Applied gene histopathology: identification of Fusarium species in FFPE tissue sections by in situ hybridization. Methods Mol Biol. 2013;968:141–7.
38. Shinozaki M, Okubo Y, Sasai D, et al. Identification of Fusarium species in formalin-fixed and paraffin-embedded sections by in situ hybridization using peptide nucleic acid probes. J Clin Microbiol. 2011;49(3):808–13.
39. Montone KT. Differentiation of Fusarium from Aspergillus species by colorimetric in situ hybridization in formalin-fixed, paraffin-embedded tissue sections using dual fluorogenic-labeled LNA probes. Am J Clin Pathol. 2009;132(6):866–70.
40. Muñoz-Cadavid C, Rudd S, Zaki SR, et al. Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR. J Clin Microbiol. 2010;48(6):2147–53.
41. Lau A, Chen S, Sorrell T, et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol. 2007;45(2):380–5.
42. Olias P, Jacobsen ID, Gruber AD. Fungal species identification from avian lung specimens by single hypha laser microdissection and PCR product sequencing. Med Mycol. 2011;49(1):56–61.
43. De Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of clinical fungi. 3rd ed. Utrecht: CD-ROM, CBS-KNAW Fungal Biodiversity Centre; 2011.
44. Guarro J, Gené J. Fusarium infections. Criteria for the identification of the responsible species. Mycoses. 1992;35(5–6):109–14.
45. Summerbell RC, Schroers HJ. Analysis of phylogenetic relationship of Cylindrocarpon lichenicola and Acremonium falciforme to the Fusarium solani species complex and a review of similarities in the spectrum of opportunistic infections caused by these fungi. J Clin Microbiol. 2002;40(8):2866–75.
46. Azor M, Gené J, Cano J, Manikandan P, Venkatapathy N, Guarro J. Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility. J Clin Microbiol. 2009;47(5):1463–8.
47. Jurado M, Vázquez C, Patiño B, González-Jaén MT. PCR detection assays for the trichothecene-producing species Fusarium graminearum, Fusarium culmorum, Fusarium poae, Fusarium equiseti and Fusarium sporotrichioides. Syst Appl Microbiol. 2005;28(6):562–8.
48. Landlinger C, Baskova L, Preuner S, Willinger B, Buchta V, Lion T. Identification of fungal species by fragment length analysis of the internally transcribed spacer 2 region. Eur J Clin Microbiol Infect Dis. 2009;28(6):613–22.
49. Ahmad S, Khan ZU, Theyyathel AM. Development of a nested PCR assay for the detection of Fusarium solani DNA and its evaluation in the diagnosis of invasive fusariosis using an experimental mouse model. Mycoses. 2010;53(1):40–7.
50. Sugawara Y, Nakase K, Nakamura A, et al. Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders. Eur J Haematol. 2013;90(4):331–9.
51. Healy M, Reece K, Walton D, et al. Use of the Diversi Lab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol. 2005;43(10):5278–80.
52. Lau A, Sorrell TC, Lee O, Stanley K, Halliday C. Colony multiplex-tandem PCR for rapid, accurate identification of fungal cultures. J Clin Microbiol. 2008;46(12):4058–60.
53. Faria CB, Abe CA, da Silva CN, Tessmann DJ, Barbosa-Tessmann IP. New PCR assays for the identification of Fusarium verticillioides, Fusarium subglutinans, and other species of the Gibberella fujikuroi complex. Int J Mol Sci. 2012;13(1):115–32.
54. Bernal-Martínez L, Buitrago MJ, Castelli MV, Rodríguez-Tudela JL, Cuenca-Estrella M. Detection of invasive infection caused by Fusarium solani and non-Fusarium solani species using a duplex quantitative PCR-based assay in a murine model of fusariosis. Med Mycol. 2012;50(3):270–5.
55. Muraosa Y, Schreiber AZ, Trabasso P, et al. Development of cycling probe-based real-time PCR system to detect Fusarium species and Fusarium solani species complex (FSSC). Int J Med Microbiol. 2014;304(3–4):505–11.
56. Gu Z, Buelow DR, Petraitiene R, Petraitis V, Walsh TJ, Hayden RT. Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction. Arch Pathol Lab Med. 2014;138(11):1474–80.
57. Scauflaire J, Godet M, Gourgue M, Liénard C, Munaut F. A multiplex real-time PCR method using hybridization probes for the detection and the quantification of Fusarium proliferatum, F. subglutinans, F. temperatum, and F. verticillioides. Fungal Biol. 2012;116(10):1073–80.
58. Baayen RP, O’Donnell K, Waalwijk C, et al. Gene genealogies and AFLP analyses within the Fusarium oxysporum complex identify monophyletic and non-monophyletic formae speciales causing wilt and rot disease. Phytopathology. 2000;90(8):891–900.
59. O'Donnell K, Sutton DA, Rinaldi MG, et al. Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin. J Clin Microbiol. 2004;42(11):5109–20.
60. Park JM, Kim GY, Lee SJ, et al. Comparison of RAPD, AFLP, and EF-1α sequences for the phylogenetic analysis of Fusarium oxysporum and its formae speciales in Korea. Mycobiology. 2006;34(2):45–55.
61. Jureen R, Koh TH, Wang G, et al. Use of multiple methods for genotyping Fusarium during an outbreak of contact lens associated fungal keratitis in Singapore. BMC Infect Dis. 2008;8:92.
62. Godoy P, Cano J, Gené J, Guarro J, Höfling-Lima AL, Lopes CA. Genotyping of 44 isolates of Fusarium solani, the main agent of fungal keratitis in Brazil. J Clin Microbiol. 2004;42(1):4494–7.
63. Wang H, Xiao M, Kong F, et al. Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study. J Clin Microbiol. 2011;49(5):1890–8.
64. Spiess B, Seifarth W, Hummel M, et al. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol. 2007;45(11):3743–53.
65. Campa D, Tavanti A, Gemignani F, et al. DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses. J Clin Microbiol. 2008;46(3):909–15.
66. Landlinger C, Preuner S, Willinger B, et al. Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology. J Clin Microbiol. 2009;474:1063–73.
67. Liao MH, Lin JF, Li SY. Application of a multiplex suspension array for rapid and simultaneous identification of clinically important mold pathogens. Mol Cell Probes. 2012;26(5):188–93.
68. Buelow DR, Gu Z, Walsh TJ, Hayden RT. Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens. Med Mycol. 2012;50(7):775–80.
69. O’Donnell K, Sarver BAJ, Brandt M, et al. Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006. J Clin Microbiol. 2007;45(7):2235–48.
70. Babady NE, Miranda E, Gilhuley KA. Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi. J Clin Microbiol. 2011;49(11):3777–82.
71. Schoch CL, Seifert KA, Huhnhof S, et al. Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi. Proc Natl Acad Sci U S A. 2012;109(16):6241–6.
72. Zhang N, O'Donnell K, Sutton DA, et al. Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J Clin Microbiol. 2006;44(6):2186–90.
73. Knutsen AK, Torp M, Holst-Jensen. Phylogenetic analyses of the Fusarium poae, Fusarium sporotrichioides and Fusarium langsethiae species complex based on partial sequences of the translation elongation factor-1 alpha gene. Int J Food Microbiol. 2004;95(3):287–95.
74. Schroers HJ, O’Donnell K, Lamprecht S, et al. Taxonomy and phylogeny of the Fusarium dimerum species group. Mycologia. 2009;101(1):44–70.
75. O’Donnell K, Nirenberg HI, Aoki T, Cigelnik E. A multigene phylogeny of the Gibberella fujikuroi species complex: detection of additional phylogenetically distinct species. Mycoscience. 2000;41:61–78.
76. Cunnington J. Novel primers developed from mitochondrial intergenic spacers are useful for multi-locus sequence typing of Fusarium oxysporum strains. Eur J Plant Pathol. 2006;116(1):77–80.
77. Debourgogne A, Gueidan C, Hennequin C, Contet-Audonneau N, de Hoog S, Machouart M. Development of a new MLST scheme for differentiation of Fusarium solani species complex (FSSC) isolates. J Microbiol Methods. 2010;82(3):319–23.
78. Yli-Mattila T, Paavanen-Huhtala S, Bulat SA, Alekhina IA, Nirenberg HI. Molecular, morphological and phylogenetic analysis of the Fusarium avenaceum/F. arthrosporioides/F. tricinctum species complex—a polyphasic approach. Mycol Res. 2002;106(6):655–69.
79. Nilsson RH, Ryberg M, Kristiansson E, Abarenkov K, Larsson KH, Kõljalg U. Taxonomic reliability of DNA sequences in public sequence databases: a fungal perspective. PLoS One. 2006;1:e59.
80. Geiser DM, Jimenez-Gasco M, Kang S, et al. FUSARIUM-ID v. 1.0: a DNA sequence database for identifying Fusarium. Eur J Plant Pathol. 2004;110:473–9.
81. Niessen L, Vogel RF. Detection of Fusarium graminearum DNA using a loop-mediated isothermal amplification (LAMP) assay. Int J Food Microbiol. 2010;140(2–3):183–91.
82. Almasi MA, Dehabadi SMH, Moradi A, Eftekhari Z, Ojaghkandi MA, Aghaei S. Development and application of loop-mediated isothermal amplification assay for rapid detection of Fusarium oxysporum f. sp. lycopersici. J Plant Pathol Microb. 2013;4:5.
83. Davari M, van Diepeningen AD, Babai-Ahari A, et al. Rapid identification of Fusarium graminearum species complex using rolling circle amplification (RCA). J Microbiol Methods. 2012;89(1):63–70.
84. Iyer MS, Cousin MA. Immunological detection of Fusarium species in cornmeal. J Food Prot. 2003;66(3):451–6.
85. Kitagawa T, Sakamoto Y, Furumi K, Ogura H. Novel enzyme immunoassays for specific detection of Fusarium oxysporum f. sp. cucumerinum and for general detection of various Fusarium species. Phytopathology. 1989;79:162–5.
86. Hill NS, Hiatt EE, Chanh TC. ELISA analysis for Fusarium in barley. Crop Sci. 2006;46:2636–42.
87. Marinach-Patrice C, Lethuillier A, Marly A, et al. Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect. 2009;15(7):634–42.
88. De Carolis E, Posteraro B, Lass-Flörl C, et al. Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect. 2012;18(5):475–84.
89. Del Chierico F, Masotti A, Onori M, et al. MALDI-TOF MS proteomic phenotyping of filamentous and other fungi from clinical origin. J Proteom. 2012;75(11):3314–30.
90. Triest D, Stubbe D, De Cremer K, et al. Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus. J Clin Microbiol. 2015;53(2):465–76.
91. Mancini V, Dapporto L, Baracchin D, Luchi N, Turillazzi S, Capretti P. Phenotypic characterization of cryptic Diplodia species by MALDI-TOF MS and the bias of mycelium age. Forest Pathol. 2013;43(6):455–61.
92. Valentine N, Wunschel S, Wunschel D, Petersen C, Wahl K. Effect of culture conditions on microorganism identification by matrix-assisted laser desorption ionization mass spectrometry. Appl Environ Microbiol. 2005;71(1):58–64.
93. Reich M, Bosshard PP, Stark M, Beyser K, Borgmann S. Species identification of bacteria and fungi from solid and liquid culture media by MALDI-TOF mass spectrometry. J Bacteriol Parasitol. 2013;S5:002. doi:10.4172/2155-9597.S5-002.
94. Buskirk AD, Hettick JM, Chipinda I, et al. Fungal pigments inhibit the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis of darkly pigmented fungi. Anal Biochem. 2011;411(1):122–8.
95. Pan YL, Kuo MT, Chang TC, Ho YP, Chang HC. Characterizing common pathogens of ocular mycoses based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Mycoses. 2012;55(S4):293.
96. Ananthi S, Venkatesh Prajna N, Lalitha P, Valarnila M, Dharmalingam K. Pathogen induced changes in the protein profile of human tears from Fusarium keratitis patients. PLoS One. 2013;8:e53018.
97. Marinach-Patrice C, Fekkar A, Atanasova R, et al. Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS One. 2010;5:e8862.
98. Khan ZU, Ahmad S, Theyyathel AM. Diagnostic value of DNA and (1→3)-beta-D-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with Fusarium oxysporum. J Med Microbiol. 2008;57(Pt1):36–42.
99. Scotter JM, Langford VS, Wilson PF, McEwan MJ, Chambers ST. Real-time detection of common microbial volatile organic compounds from medically important fungi by selected ion flow tube-mass spectrometry (SIFT-MS). J Microbiol Methods. 2005;63(2):127–34.
100. Stępień L. The use of Fusarium secondary metabolite biosynthetic genes in chemotypic and phylogenetic studies. Crit Rev Microbiol. 2014;40(2):176–85.
101. Thrane U. Grouping Fusarium section Discolor isolates by statistical analysis of quantitative high performance liquid chromatographic data on secondary metabolite production. JMicrobiol Meth. 1990;12:23–39.